恒瑞医药(01276.HK)10月22日耗资65万元回购1万股A股

Core Viewpoint - Heng Rui Pharmaceutical (01276.HK) announced a share buyback plan, indicating confidence in its stock value and commitment to returning capital to shareholders [1] Group 1 - The company plans to repurchase 10,000 A-shares at a total cost of RMB 650,000 [1] - The buyback price is set at RMB 65 per share [1] - The transaction is scheduled for October 22, 2025 [1]